IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $29,999,000 | -4.7% | 1,542,410 | -18.5% | 0.01% | 0.0% |
Q4 2017 | $31,494,000 | -10.8% | 1,891,554 | +8.8% | 0.01% | -15.4% |
Q3 2017 | $35,292,000 | +205.2% | 1,738,517 | +142.1% | 0.01% | +225.0% |
Q2 2017 | $11,563,000 | -68.7% | 718,225 | -75.4% | 0.00% | -66.7% |
Q1 2017 | $36,970,000 | -30.9% | 2,922,492 | -27.6% | 0.01% | -33.3% |
Q4 2016 | $53,510,000 | -41.6% | 4,038,460 | +4.4% | 0.02% | -41.9% |
Q3 2016 | $91,675,000 | -6.5% | 3,868,146 | +13.7% | 0.03% | -13.9% |
Q2 2016 | $98,029,000 | -11.2% | 3,401,416 | -1.3% | 0.04% | -20.0% |
Q1 2016 | $110,404,000 | -26.8% | 3,447,963 | -2.3% | 0.04% | -25.0% |
Q4 2015 | $150,891,000 | +36.5% | 3,528,784 | +12.4% | 0.06% | +27.7% |
Q3 2015 | $110,559,000 | -21.5% | 3,140,020 | +2.4% | 0.05% | -14.5% |
Q2 2015 | $140,879,000 | -9.8% | 3,067,923 | -8.0% | 0.06% | -8.3% |
Q1 2015 | $156,246,000 | +49.2% | 3,333,612 | +0.8% | 0.06% | +50.0% |
Q4 2014 | $104,731,000 | +23.5% | 3,305,949 | -7.5% | 0.04% | +17.6% |
Q3 2014 | $84,777,000 | -11.5% | 3,575,594 | +12.0% | 0.03% | -10.5% |
Q2 2014 | $95,765,000 | +118.8% | 3,193,231 | +92.7% | 0.04% | +111.1% |
Q1 2014 | $43,770,000 | +26.5% | 1,656,674 | +20.4% | 0.02% | +28.6% |
Q4 2013 | $34,592,000 | +34.0% | 1,375,966 | +9.1% | 0.01% | +27.3% |
Q3 2013 | $25,818,000 | +35.1% | 1,261,286 | +31.6% | 0.01% | +22.2% |
Q2 2013 | $19,115,000 | – | 958,720 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |